chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in her chest all the way to her arm; Pain in her chest all the way to her arm; This is a spontaneous report received from Pfizer-sponsored program. A contactable consumer (patient's spouse) reported that a female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient has a scheduled appointment for a second dose due on 06Apr2021. The reporter wanted to reschedule because the patient was in the hospital and won't be able to get it on the scheduled date. Patient was hospitalized because she had pain in her chest all the way to her arm on unspecified date in 2021. The outcome of event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report was received from a pharmacist referring to a male patient of unknown age. On 28-NOV-2017, the patient was vaccinated with a dose of ROTATEQ, oral (dose, lot number and expiration date not reported) for prophylaxis. The pharmacist reported 15 minutes after administration of the ROTATEQ patient "threw up". It was unknown which dose in the series of ROTATEQ was received. The outcome of the event was unknown. The reporter did not assess the causality.
- "Heaviness in chest (but no SOB). - Sore throat. - Approx 6" rash around injection site.
Fever Couldn't talk Sharp join & chest pains Painful to move eyes Fatigue Bedridden- couldn't move on my own Shortness of breath  Lasted 7 hours; took 3 Tylenol @ 500mg each; lots of fluids
Initial onset was dizziness, mild nausea and headache. By second day severe nasal congestion and sore throat. Went to urgent care at work and doc said the symptoms could last 2 days. Rest and fluids. Home the next day and escalating symptoms ..by 2 am on the 3rd day 103 fever. Was alone so didn't go to ER. After 8 hours, fever broke. Two more days and still recovering. Because of my dehydration, I experienced a sever muscle spasm in my low back.
Sore and redness at sight, heat.  Gradually spread over the next 24 hours.  On 10/10/12 in the evening hours has wheezing and shortness of breath.  Went to MD on 10/11/12.  Has not experienced allergic reaction to flu vaccine in the past.  MD prescribed antihistamine.
Severe Menstrual Bleeding and cramping to include major blood clots in menstruation so heavy that need to use adult diapers over menstrual pads
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with (Oka/Merck) VARIVAX (dose, route, lot # and expiration date were not provided), which were exposed to temperatures outside of the recommended range incorrect product storage). No adverse effects had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
12/18/20- reports suddenly got sweaty, hands felt cold, then got nauseous. Reports vomitted x 1. Reports the rest of the day felt tachycardiac for a few hours (HR 120-140) and dizzy. Started getting muscle aches/joint aches. Denies any recent COVID exposure. Tested positive for COVID In 8/2020. Reports hips/knees are throbbing today; Heart rate WNL.   ///    Presenting today due to intermittent presyncope and palpitations. Also notes generalized weakness. Patient evaluate 2 L of fluid given her Mirena IUD D-dimer was sent which was negative patient with no pleuritic symptoms or dyspnea to suggest pulmonary embolism. Otherwise hemodynamically stable on exam ambulates with no difficulty no focal neurologic deficits. Patient did describe on her initial presentation that she noted some weakness of her bilateral legs. Given her possible viral reaction and description of weakness it is possible the patient is developing an early autoimmune reaction however she has no evidence of GuillainBarré or transverse myelitis on my exam. We will plan to discharge with neurology follow-up as outpatient.
Pt recv vax on 6/13/96; on 3/6/99 pt exp chicken pox; tx=Benadryl, Calamine lotion, Advil
1/13/21: Via email, client stated on 01/13/2021 @ 5:45 AM she noticed the injection site on left upper arm was red and hot aprox. 3" x 2" in size, and was very itchy with some soreness.  01/20/21 @ 10:30 AM spoke with client who stated the redness faded but there was a red streak running down the upper arm with warmness to site. Client stated she had a phone appointment on 1/15/21 with PCP who told her to monitor the site.  Client stated on 1/16/21 the redness or warmth to site was resolved. RN
she was not feeling well after getting second dose of covid-19 vaccine; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (first dose), for COVID-19 immunization. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "she was not feeling well after getting second dose of covid-19 vaccine". Additional information: the patient also wanted to know how to reschedule her husband's second dose of covid-19 vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been reported in a CDC slide titled as "Safety of PNEUMOVAX 23 in the Vaccine Adverse Reporting System (VAERS)". This spontaneous prospective pregnancy report as received from a registered nurse (RN) in Centers for Disease Control and Prevention (CDC) concerning a female patient of unknown age, 5 of the five patients who experienced local reactions. On an unknown date, the patient became pregnant. The last menstrual period (LMP) and estimated date of delivery (EDD) was not known. On an unknown date the patient was administered with a dose of PNEUMOVAX 23 (lot#, dose and route were unspecified) during pregnancy. On an unknown date the patient experienced local reactions. The outcome of local reactions was unknown. The pregnancy outcome was unknown. This is one of the 18 reports (PNEUMOVAX 23 administered during pregnancy) that received from the same source. Additional information has been requested.
she noticed redness at the vaccination site.; she noticed soreness at the vaccination site.; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (she noticed redness at the vaccination site.) and VACCINATION SITE PAIN (she noticed soreness at the vaccination site.) in a 121-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 050E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). On 07-Nov-2021, the patient experienced VACCINATION SITE ERYTHEMA (she noticed redness at the vaccination site.) and VACCINATION SITE PAIN (she noticed soreness at the vaccination site.). At the time of the report, CHILLS (Chills), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (she noticed redness at the vaccination site.) and VACCINATION SITE PAIN (she noticed soreness at the vaccination site.) outcome was unknown.            Concomitant medication list was not provided.  No medical history information was reported.  Treatment information was not provided.
grandma states pt began w/high pitched shrill cry which cont through entire noc; cry began short time following inject but grandma does not know exactly what time; pt was seen by MD following day but no testing or treatment was done; t103;
Information has been received from a consumer concerning an 18 month old female with no allergies or medical history who in April 2005, was vaccinated SC with a 0.5ml dose of varicella virus vaccine live (lot #645051/0200N) that expired on Feb 19 2005. There was no concomitant therapy. It was reported that in May 2005, the patient developed a high fever and dehydration. Unspecified medical attention was sought and the patient was subsequently hospitalized for two nights and three days. After therapy (unspecified), the patient subsequently recovered from the high fever and dehydration.
Patient was at the vaccine site. Patient was in waiting area after receiving vaccine, and reported to me, she felt a little weak because she had not eaten yet that day. Patient then reported she felt like she was going to pass out and grabbed on to my legs. I held her with my hand on her back, and I waved and shouted for help. The Paramedics on site came to assess patient, and took over caring for the patient. The patient never lost consciousness, she was fed a granola bar, and was able to leave on her own.
This spontaneous report was received from a pharmacy technician referring to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients may had received improperly stored doses of RECOMBIVAX HB "2.5/0.5" (units not provided), lot number: M037248, expiration date 01-FEB-2019 and lot number reported as M040423, expiration date 03-JUL-2019 (dose and route of administration were not reported) for prophylaxis. There was no adverse effect reported.  Administered doses of RECOMBIVAX HB were exposed to a temperature excursion of 47°F to 77°F for 2 hours. There were no previous excursions reported. Additional information has been requested.
BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: PA-C Admission Date: 8/31/2023 Discharge Date: 9/6/2023      DETAILS OF HOSPITAL STAY:   Clinical Narrative:   The patient is a 66-year-old gentleman with a polysubstance use disorder who presented with anasarca and required diuresis.  He suffered some degree of acute kidney injury which required adjustment in his diuretic dosing.  He was noted to be in alcohol withdrawal and was on the Institute protocol.  Many of his symptoms seemed to be more anxiety related and he was transitioned from the Institute to the objective-measure only approach.  Psychiatry was also consulted.  A number of medication changes were made with respect to his psychotropics.  It is encouraged that he seek outpatient psychiatry services.  It was felt that subacute rehab would be most advantageous to him.  Given his COVID status and treatment for COVID-pneumonia, the rehab locations available to him were not acceptable to him and he continued to decline them.  After a period of time he did improve sufficiently to be discharged home though he continued to decline subacute rehab through the day of discharge.  He is felt to be at extremely high risk of readmission given his multiple complex comorbidities, polysubstance use disorder, social determinants of health, and his refused subacute rehab placement.
Patient had 2 doses of COVID Pfizer vaccine, on 3/4/21, and 3/24/21.  Patient was admitted for resp failure on 10/16/21, and is still hospitalized on 10/19/21
Left arm started afternoon of day received vaccine with redness and raised area size of quarter and increased in size of warmth each day. Seen in office 05/12/2004 5x10cm area of erythema. 2cm central darker erythema and warmth + underlying edema--though to be large local reaction to DTaP--started on Atarax 10mg every 4 hours PRN.
1-3hr p/vax lightheaded, chest tightness, SOB ( no stridor or resp distress);amb to ER w/ IV-Lactated Ringers, unk pain med 20 hr p/gen malaise, aches/pains;rx ibuprofen PRN;
I experienced a mini-stroke (TIA) in which my speech was affected and which resulted in me being hospitalized.  For about 5 minutes, I was unable to find words and properly communicate.  I went to the ER and was admitted and had a battery of tests, kept overnight, and discharged the following day  My statin dose was increased, and I was put on a baby aspirin, in addition to Pradaxa blood thinner.  i believe that I may have had a vascular thrombi related to the effect of the medicine/spike protein.
Monitor called for assistance due to patient was not feeling well.  RN immediately at patients side and 2nd RN  then to assist patient to the floor because she felt dizzy.  Patient on the floor on her right side and then she became unresponsive.  911 called immediately after pt. was unresponsive.  3rd nurse at patients side with smelling salts  and she aroused with the smelling salts.  Pulse was strong and steady.  Patient unable to answer questions at times.  Informed RNs that she has a defibrillator and chronic kidney disease and her chest/ kidney hurt. Patient able to answer all questions at this time.  She was able to dial her phone and RN spoke with parents out in parking lot.  2 RNS at patients side at all times.  Mother arrived and stated this happens quite often. EMS arrived and patient  taken to the local hospital  for evaluation.
Unexplained bruising - first bruise on Saturday,(5/1/21), woke up with three more bruises today (5/4/21)
My heart started racing and my apple watch was saying I was an afib. My heart rate was at 150 BPM for 2 days. I went to the cardiologist but by then it had gone down. He saw the records on the phone and put me on a heart monitor and then put me on medication. I still take the medication but no more afib episodes have happened. Name of the medication is ELIQUIS and diltiazem hydrochloride.
2 weeks after having had an MMR, Pt developed a painful 3cm area of induration with surrounding erythema to the injection site. MMR was given on 4/17/06. Pt seen today 5/9/06 for first time since MMR was given. Placed on Cephalexin 500 MD QIB.
It was MMRV by Merck Lot # T027114 exp. 02/07/2022 that was given 02/08/2022 to one of my grandchildren; This spontaneous report was received from a consumer and refers to a child patient (also reported as grandchildren) of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 08-FEB-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella, and varicella (OKA-MERCK) virus vaccine live (PROQUAD) injection, therapy type: rHA, valid lot #T027114, expiration date: 07-FEB-2022, administered for prophylaxis (dose, frequency, strength, anatomical location, and route of administration were not provided) (Expired product administered).
Sedation, Palpitations, on Day 3 - weakness, palpitations, sleepiness Narrative:
Pharmacist gave the flu shot, jabbed a long needle in my upper left arm & felt pain immediately. I was sitting & he was standing over me when he injected the shot. Pain was not the usual 2-3 day discomfort. It was intermittent but has progressed over time. Cannot lift my arm overhead & behind me, cannot sleep on my left side. Researched arm pain after a flu vaccine and many articles popped up describing my exact pain as SIRVA. Never heard of this before. I have received a yearly flu shot due to my age & working in healthcare for 28 years, a RN always gave the shots. This was the first time going to a pharmacy for the flu shot.
LT arm swelled, hot, pain, hives. Dizzy chills sweats nauseated. Still remains nauseated with chills pain in back of lungs.
Pink/purple rash began on legs over the course of 24 hours was spread to torso and face.
my ears built up tremendous pressure behind them/My ears were sensitive to the slightest pressure change; my Eustachian tubes collapsed; I developed tinnitus in both ears; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient did receive the first dose of the vaccine, within 7 hours his/her ears built up tremendous pressure behind them. Eustachian tubes collapsed and patient had to continually try to pop his/her ears for 2 weeks. His/her ears were sensitive to the slightest pressure change. Patient had to pop the ears frequently. Shortly after eustachian tubes collapsed, patient developed tinnitus in both ears. It has not gone away. Patient had never had any problems with the ears prior to receiving this vaccine so he/she had made the assumption, this was the result of the vaccine. Patient decided not to take the second dose. For fear, the side effects would worsen. Outcome of tinnitus was not recovered, and outcome of other events was unknown.
Information has been received from a 66 year old male consumer concerning himself with penicillin allergy and no other pertinent medical history who in approximately December 2006 ("end of 2006"), was vaccinated with a dose of ZOSTAVAX (Merck) (lot# not reported). There was no concomitant medication. In approximately December 2006 ("end of 2006"), the patient experienced a mild irritation at the injection site. No medical attention was sought. There were no laboratory diagnostics studies performed. The patient recovered within a couple of hours. The consumer also reported that when receiving a tetanus shot (manufacturer unspecified) he had injection site irritation that lasted for a few days. No further information is available.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 77-year-old female patient who received SHINGRIX for prophylaxis. On 10th September 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 22nd September 2018, 12 days after receiving SHINGRIX, the patient experienced shingles, pruritus, tingling and erythema. On an unknown date, the outcome of the shingles, pruritus and tingling were not recovered/not resolved and the outcome of the erythema was unknown. It was unknown if the reporter considered the shingles, pruritus, tingling and erythema to be related to SHINGRIX. Additional details were provided as follows: The patient stated that she noticed red marks around her waist and on her back that were itchy and tingling. The patient went to visit her primary doctor and her primary doctor referred her to another physician. The physician then diagnosed the patient with Shingles. The patient stated that the doctor did not prescribe anything for the Shingles. This case has been linked with US2018174666, reported by the same reporter.
A 57 year old female patient with a clinical picture of 3 days of evolution consisting of colicky pain in the right flank radiating to the lumbar region, with fever quantified at 39 on Wednesday 01/13/22, it is focused as a urinary infection with renal lithiasis. Later, on 01/14/22 at approximately 3:00am, I understood that she presented mucocutaneous pallor, vomiting and hypotension. At 1pm on the same day dyspnea, tachypnea, hemodynamically unstable patient, saturation at 88 approximately does not improve with non-invasive oxygenation, presence of metabolic acidosis for which it is decided to intubate, patient has cardiac arrest that lasts approximately 5 minutes, he is referred to the ICU, on the way he makes 3 cardiac arrests. And on 01/15/22 he dies.
Patient developed redness on her ear the evening of 2/14/08 around 800pm, then redness at the back of her neck. She then developed a red welt like rash on both arms from shoulder to mid arms, large welts on her back. No rash on her face, but did have a few spots on both feet. Parent gave 25mg of Benadryl, the rash continued to spread, but completely resolved by morning.
Information has been received from a physician concerning a 26 year old female with no known allergies or reported medical history who on 07-JAN-2009 was vaccinated with the first and only dose of GARDASIL (lot# 661531/1311X) 0.5 ml, I.M. route. Concomitant therapy included NECON 1/35. On 08-APR-2009, the patient experienced deep vein thrombosis. The patient was treated with anticoagulation therapy including LOVENOX and COUMADIN. Subsequently, the patient was recovered. The physician stated that "clots can be dangerous" and deep vein thrombosis was considered to be immediately life-threatening. Additional information has been requested.   8/10/09 ER Records received DOS 4/9/09. Assessment: Soleal vein thrombosis left mid calf. Patient presents with pain of left calf exacerbated by walking/movement. Stopped taking birth control pills today.  8/17/09 Consultant records received DOS 4/13/09 to 6/04/09. Assessment: Acute DVT left perineal and soleus veins. Patient reported to physican's office with left leg pain and was sent to ER for initiation of therapy for DVT. Placed on anticoagulation. Sent to consultant's office for follow-up. Presents with left calf tenderness. Urinary tract infection. left ear pain, congested, pressure and slight dizziness. Increased anxiety. Fatigue. Tympanic membranes show serous fluid accumulation.
his 64-year-old male with a history of atrial fibrillation, asthma, hypertension, diabetes mellitus and hyperlipidemia comes to the ED for the complaint of chest pain that started approximately 2 hours ago and got worse subsequently.  The pain was located in the middle of the chest.  There was no specific aggravating or relieving factor.  It radiates to an area in between the shoulder blades and up into the neck.  The patient appears very uncomfortable at the time of this examination.  He also complains of a mild shortness of breath.  The patient states that he underwent an "ablation" 1 week ago.
Myalgia, Fever, CoughWheeze & NauseaVomiting Narrative:
VEGETABLE STATE; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included: cold, and fatigue. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, 1 total start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced vegetable state, wheelchair, and lost health. It was reported as " Wife now a vegetable state after talking the Covid vaccines .Cain and wheelchair, Lost her job ! And her health". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from vegetable state. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220244559-covid-19 vaccine ad26.cov2.s-vegetable state. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Accidentally administered Influenza vaccine (6-35 month) instead of PENTACEL.
Vaccine was given late. First dose given on 5/4/2021 Lot # 025B21A. Second dose given on 6/24/2021, Moderna, Lot # 025B21A.
Multiple strokes resulting from blood clots starting 10 days past 2nd shot. Fuzzy headed with headache prior to strokes.